Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Sahar, Bajis"'
Autor:
Anna Levinsson, Camille Zolopa, Farzaneh Vakili, Sasha Udhesister, Nadine Kronfli, Mathieu Maheu-Giroux, Julie Bruneau, Heather Valerio, Sahar Bajis, Phillip Read, Elisa Martró, Lisa Boucher, Leith Morris, Jason Grebely, Adelina Artenie, Jack Stone, Peter Vickerman, Sarah Larney
Publikováno v:
EClinicalMedicine, Vol 72, Iss , Pp 102596- (2024)
Summary: Background: People who inject drugs (PWID) are a priority population in HCV elimination programming. Overcoming sex and gender disparities in HCV risk, prevention, and the cascade of care is likely to be important to achieving this goal, but
Externí odkaz:
https://doaj.org/article/75faa34443af4e1c83a31867aa55d923
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 9, Iss , Pp 100217- (2023)
Background: Community pharmacists like other health care professionals in Lebanon have been grappling with a series of multifaceted, country-wide and ongoing challenges that have formed the impetus for this research. We aimed to explore experiences o
Externí odkaz:
https://doaj.org/article/944d0596f4474627af40108b73f71bca
Autor:
Doris Burtscher, Rafael Van den Bergh, Masood Nasim, Gbane Mahama, Sokhieng Au, Anita Williams, Abdul Sattar, Suzanne Penfold, Catherine Van Overloop, Sahar Bajis
Publikováno v:
PLoS ONE, Vol 16, Iss 11 (2021)
Background Antibiotic resistance is a growing public health threat. In Afghanistan, high levels of indiscriminate antibiotic use exist, and healthcare programmes are not informed by understanding of local attitudes towards rational antibiotic use. M
Externí odkaz:
https://doaj.org/article/afe04a1f4925474bbdb52863ebf5b158
Autor:
Samira, Hosseini-Hooshyar, Behzad, Hajarizadeh, Sahar, Bajis, Matthew, Law, Naveed Z, Janjua, Daniel S, Fierer, David, Chromy, Jürgen K, Rockstroh, Thomas C S, Martin, Patrick, Ingiliz, Chien-Ching, Hung, Gregory J, Dore, Marianne, Martinello, Gail V, Matthews
Publikováno v:
The Lancet HIV. 9:e414-e427
The benefits of direct-acting antivirals towards the elimination of hepatitis C virus (HCV) in people living with HIV are decreased when individuals are reinfected with HCV following treatment. We aimed to systematically review the existing evidence
Autor:
Maryam Alavi, Sahar Bajis, Matthew Law, Jason Grebely, Jacob George, Heather Valerio, Naveed Z. Janjua, Mel Krajden, Louisa Degenhardt, Gregory J. Dore, Gail V. Matthews, Marianne Martinello, Shane Tillakeratne, Hamish McManus, Janaki Amin
Publikováno v:
Clinical Infectious Diseases. 73:2037-2044
Background People who inject drugs are at greater risk of hepatitis C virus (HCV) infection and hospitalization, yet admissions are not utilized for HCV treatment initiation. We aimed to assess the extent to which people with HCV notification, includ
Autor:
Evan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, Clare E French, Rachel Roche, Alison D Marshall, Guillaume Fontaine, Anna Conway, Braulio M Valencia, Sahar Bajis, Justin Presseau, John W Ward, Louisa Degenhardt, Gregory J Dore, Matthew Hickman, Peter Vickerman, Jason Grebely
Publikováno v:
Cunningham, E B, Wheeler, A, Hajarizadeh, B, French, C E, Roche, R, Marshall, A D, Fontaine, G, Conway, A, Valencia, B M, Bajis, S, Presseau, J, Ward, J, Degenhardt, L, Dore, G J, Hickman, M, Vickerman, P T & Grebely, J 2022, ' Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection : a systematic review and meta-analysis ', The Lancet Gastroenterology and Hepatology, vol. 7, no. 5, pp. 426-445 . https://doi.org/10.1016/S2468-1253(21)00471-4
BackgroundDespite the goal set by WHO to eliminate hepatitis C virus (HCV) as a public health threat, uptake of HCV testing and treatment remains low. To achieve this target, evidence-based interventions are needed to address the barriers to care for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9275bbbb3b2ad3ae34eaeed3bac2ec7d
https://research-information.bris.ac.uk/ws/files/305400474/Cunnigham_Interventions_Systematic_Review_Accepted.pdf
https://research-information.bris.ac.uk/ws/files/305400474/Cunnigham_Interventions_Systematic_Review_Accepted.pdf
Autor:
Fengyi Jin, Gail V. Matthews, Andrew E. Grulich, Sahar Bajis, Virginia Macdonald, Rachel Baggaley, Bradley Mathers, Gregory J. Dore, Annette Verster, Niklas Luhmann
Publikováno v:
The Lancet Gastroenterology & Hepatology. 6:39-56
Summary Background WHO has set targets for hepatitis C virus (HCV) elimination by 2030. We did a global systematic review of HCV prevalence and incidence in men who have sex with men (MSM) to provide updated estimates that can guide community educati
Publikováno v:
The Journal of Infectious Diseases. 222:S758-S772
The World Health Organization has set a goal to eliminate hepatitis C virus (HCV) infection as public health threat by 2030. Although the advent of highly effective and tolerable direct-acting antiviral therapy has paved the way for HCV elimination,
Autor:
Nicolas Legrand, Skye McGregor, Rowena Bull, Sahar Bajis, Braulio Mark Valencia, Amrita Ronnachit, Lloyd Einsiedel, Antoine Gessain, John Kaldor, Marianne Martinello
Publikováno v:
Clinical Microbiology Reviews
Clinical Microbiology Reviews, 2022, 35 (2), pp.e0007821. ⟨10.1128/cmr.00078-21⟩
Clin Microbiol Rev
Clinical Microbiology Reviews, 2022, 35 (2), pp.e0007821. ⟨10.1128/cmr.00078-21⟩
Clin Microbiol Rev
International audience; Human T-lymphotropic virus type 1 (HTLV-1) is estimated to affect 5 to 10 million people globally and can cause severe and potentially fatal disease, including adult T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::460b7533e9798dcd7c26a3bfbc4095e1
https://hal-pasteur.archives-ouvertes.fr/pasteur-04079406
https://hal-pasteur.archives-ouvertes.fr/pasteur-04079406
Publikováno v:
Gastroenterology Clinics of North America. 49:253-277
The World Health Organization has called for the elimination of hepatitis C virus (HCV) as a public health threat by 2030. Highly effective direct-acting antiviral agents provide the therapeutic tools required for elimination. In the absence of a vac